Integrated Management Approach to Atrial Fibrillation Care: A Cost Utility Analysis

Can J Cardiol. 2019 Sep;35(9):1142-1148. doi: 10.1016/j.cjca.2019.04.016. Epub 2019 Apr 23.

Abstract

Background: Atrial fibrillation (AF) is a substantial burden on health care. Combined specialist and nurse-based AF clinics are associated with improved outcomes. However, Canadian data on the cost-effectiveness of this integrated management approach to AF care are lacking.

Methods: We evaluated health care costs and outcomes of 413 patients with newly-diagnosed AF in 3 emergency departments in Nova Scotia between January 1, 2011 and January 31, 2014. Using a before-after study design, patients were divided into usual care (228 patients) and intervention (185 patients) groups. The intervention was a nurse-run, physician-supervised AF clinic. Costs and quality-adjusted life years (QALYs) were compared between usual care and intervention. Costs were those incurred because of the clinical outcome, bleeding events, medications, and cardiovascular-related procedures. Probabilistic analysis was conducted to assess uncertainty.

Results: The AF clinic was associated with an average cost reduction of CAD$210.83 and an average improvement in QALY of 0.0007 per patient. The AF clinic was dominant over usual care despite higher operational and medication costs over 1 year. It provided greater cost-saving in approximately 66% of probabilistic analysis simulations and generated more QALYs in approximately 92% of simulations. An incremental cost-effectiveness ratio < $50,000 was found in 68% of simulations.

Conclusions: The present study provides guidance regarding the cost-effectiveness of an integrated management approach compared with usual specialty care of AF in a Canadian setting. We recommend further study be undertaken that prospectively plans for economic evaluation before definitive assessments of cost-effectiveness can be made.

Publication types

  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Atrial Fibrillation / economics*
  • Atrial Fibrillation / mortality
  • Atrial Fibrillation / therapy
  • Costs and Cost Analysis
  • Decision Making
  • Disease Management*
  • Female
  • Follow-Up Studies
  • Health Care Costs*
  • Humans
  • Male
  • Middle Aged
  • Nova Scotia / epidemiology
  • Prognosis
  • Quality of Life
  • Retrospective Studies
  • Survival Rate / trends